채용
Benefits & Perks
•Team events and activities
•Competitive salary and equity package
•Professional development budget
•Generous paid time off and holidays
•Comprehensive health, dental, and vision insurance
•Equity
•Learning
•Healthcare
Required Skills
React
TypeScript
Python
Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.
We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.
GRAIL is headquartered in the bay area of California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies.
For more information, please visit grail.com
The role assists with regulatory strategy and the development of submissions in partnership with key internal and external stakeholders for GRAIL projects, including Multi-Cancer Early Detection (MCED). The position supports the U.S. Regulatory team in preparing Investigational Device Exemptions (IDEs), IDE supplements, pre-submissions, Premarket Approvals (PMAs), annual reports, and other relevant documentation.
The role collaborates cross-functionally with Quality, Lab Operations, and other stakeholders to support regulatory strategy development, product validation, audits, promotional material review, on-market product support, and change control processes. This individual monitors and communicates changes in regulatory policies and In Vitro Diagnostic (IVD) requirements to project teams and leadership. They may manage and provide direction to regulatory staff and, when required, participate in senior management meetings as a delegate. The role fosters a work culture aligned with GRAIL’s values
You are approved to work remotely. While your primary workplace is your home, you may be required to travel occasionally to a GRAIL office or other locations to perform your work or attend team-related events.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

Senior Solutions Engineer - East Coast
LaunchDarkly · Remote - US

New Graduate Engineer, Mechanical (Cape Canaveral)
SpaceX · Rockledge, FL

Staff Electrical Engineer
Oura · Hybrid - San Diego, California; Hybrid - San Francisco, California

Senior Staff Software Engineer - Data Lakes
Fivetran · Remote, Germany, EMEA

Compliance Specialist
M1 Finance · Chicago
About Grail

Grail
Series CBiotechnology company.
201-500
Employees
Menlo Park
Headquarters
$3.2B
Valuation
Reviews
3.3
9 reviews
Work Life Balance
3.2
Compensation
3.8
Culture
2.8
Career
3.5
Management
2.1
45%
Recommend to a Friend
Pros
Great mission and purpose
Good coworkers and supportive teams
Competitive pay and solid benefits
Cons
Poor leadership and management issues
Large layoffs and workplace instability
Work life balance varies by department
Salary Ranges
167 data points
Senior/L5
Senior/L5 · Senior Analytical Engineer
3 reports
$187,544
total / year
Base
$163,039
Stock
-
Bonus
-
$180,790
$195,500
Interview Experience
5 interviews
Difficulty
2.6
/ 5
Duration
14-28 weeks
Offer Rate
20%
Experience
Positive 80%
Neutral 20%
Negative 0%
Interview Process
1
Application Review
2
Recruiter/Talent Acquisition Screen
3
Hiring Manager Interview
4
Stakeholder/Panel Interviews
5
Assessment/Technical Evaluation
6
Offer
Common Questions
Behavioral/STAR
Past Experience
Technical Knowledge
Role-specific Assessment
Culture Fit
News & Buzz
GRAIL Submits FDA Premarket Approval Application for Galleri Multi-Cancer Early Detection Blood Test - Patient Care Online
Source: Patient Care Online
News
·
5w ago
GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test - Yahoo Finance
Source: Yahoo Finance
News
·
5w ago
Trifecta Capital Advisors LLC Purchases 10,250 Shares of GRAIL, Inc. $GRAL - MarketBeat
Source: MarketBeat
News
·
5w ago
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PR Newswire
Source: PR Newswire
News
·
5w ago